How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Apex BioTechnology Corp. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
35 clearance records and 0 recall records in the covered releases, across 1 source company names and 5 product codes. Dated history runs from Jan 22, 2001 to Apr 4, 2025.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| AUTOSURE VOICE II BLOOD GLUCOSE MONITORING SYSTEM AND TEST STRIPSK102037 · CGA | Apex BioTechnology Corp. | 510(k) | Aug 13, 2010FDA decision date |
| CONTREX PLUS LOW CONTROL SOLUTIONK100747 · JJX | Apex BioTechnology Corp. | 510(k) | Apr 14, 2010FDA decision date |
| AUTOSURE VOICE BLOOD GLUCOSE MONITORING SYSTEM, MODEL AS90011F9K090043 · CGA | Apex BioTechnology Corp. | 510(k) | Apr 9, 2009FDA decision date |
| GLUCOSURE STAR BLOOD GLUCOSE MONITORING SYSTEM, MODEL AS90000E1K073648 · CGA | Apex BioTechnology Corp. | 510(k) | Apr 10, 2008FDA decision date |
| GLUCOSURE VOICE BLOOD GLUCOSE MONITORING SYSTEM, MODEL AS90011E1K073137 · NBW | Apex BioTechnology Corp. | 510(k) | Apr 1, 2008FDA decision date |
| ASSURE 4 BLOOD GLUCOSE MONITORING SYSTEMK070088 · NBW | Apex BioTechnology Corp. | 510(k) | Feb 16, 2007FDA decision date |
| GLUCO TRACK BLOOD GLUCOSE MONITORING SYSTEMK062799 · CGA | Apex BioTechnology Corp. | 510(k) | Feb 6, 2007FDA decision date |
| MODIFICATION TO GLUCOSURE BGM SYSTEM, MODEL 221100K011233 · CGA | Apex BioTechnology Corp. | 510(k) | May 18, 2001FDA decision date |
| GLUCOSURE BLOOD GLUCOSE MONITORING SYSTEMK002621 · CGA | Apex BioTechnology Corp. | 510(k) | Jan 22, 2001FDA decision date |
| GLUCOSMART BLOOD GLUCOSE MONITORING SYSTEMK002624 · CGA | Apex BioTechnology Corp. | 510(k) | Jan 22, 2001FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.